News
has acknowledged receipt of the resubmission of the Biologics License Application (BLA) for ONS-5010 (bevacizumab-vikg), an investigational ophthalmic formulation of bevacizumab for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback